Healthcare -
Biotechnology - NASDAQ - US
$ 1.02
-2.17 %
$ 57.6 M
Market Cap
-0.58
P/E
PRLD - CASH FROM OPERATIONS
Cash from Operations PRLD - Prelude Therapeutics Incorporated
-103 M
LAST VALUE
-10.85%
2 YEAR CAGR
-32.01%
5 YEAR CAGR
0.00%
10 YEAR CAGR